BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10832771)

  • 21. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children.
    Reinehr T; de Sousa G; Andler W
    Obes Res; 2005 Oct; 13(10):1824-33. PubMed ID: 16286531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal relation between body mass index and renal function in individuals with hypertension and excess body weight.
    Gonçalves Torres MR; Cardoso LG; de Abreu VG; Sanjuliani AF; Francischetti EA
    Nutrition; 2009 Sep; 25(9):914-9. PubMed ID: 19446436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
    Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial.
    McMillan-Price J; Petocz P; Atkinson F; O'neill K; Samman S; Steinbeck K; Caterson I; Brand-Miller J
    Arch Intern Med; 2006 Jul; 166(14):1466-75. PubMed ID: 16864756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The study on relationship of body mass index and blood pressure in children and adolescents of Beijing].
    Wang WJ; Wang KA; Chen CM; Cao RX; Bai YM; Ma LM; Ren ZY; Niu ZH; Gao Q
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):109-12. PubMed ID: 15132860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between body weight and blood pressure.
    Staessen J; Fagard R; Amery A
    J Hum Hypertens; 1988 Dec; 2(4):207-17. PubMed ID: 3070038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity.
    Shargorodsky M; Fleed A; Boaz M; Gavish D; Zimlichman R
    Int J Obes (Lond); 2006 Nov; 30(11):1632-8. PubMed ID: 16552402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reductions of body weight and blood pressure in obese hypertensive patients treated by diet. A retrospective study.
    Novi RF; Porta M; Lamberto M; Molinatti GM
    Panminerva Med; 1989; 31(1):13-5. PubMed ID: 2726283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight reduction in obese hypertensive patients.
    Cohen MD; D'Amico FJ; Merenstein JH
    Fam Med; 1991 Jan; 23(1):25-8. PubMed ID: 2001777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a weight-loss program on mental stress-induced cardiovascular responses and recovery.
    Torres SJ; Nowson CA
    Nutrition; 2007; 23(7-8):521-8. PubMed ID: 17560080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Weight reduction improves high blood pressure and microalbuminuria in hypertensive patients with obesity].
    Ohashi H; Oda H; Ohno M; Watanabe S
    Nihon Jinzo Gakkai Shi; 2001 May; 43(4):333-9. PubMed ID: 11431901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.
    Reisin E; Abel R; Modan M; Silverberg DS; Eliahou HE; Modan B
    N Engl J Med; 1978 Jan; 298(1):1-6. PubMed ID: 337144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and the sympathetic nervous system.
    Grassi G; Cattaneo BM; Seravalle G; Colombo M; Cavagnini F; Mancia G
    Blood Press Suppl; 1996; 1():43-6. PubMed ID: 9162437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
    Hendricks EJ; Greenway FL; Westman EC; Gupta AK
    Obesity (Silver Spring); 2011 Dec; 19(12):2351-60. PubMed ID: 21527891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.